Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression

A 66-year old man known case of metastatic castration resistant prostate cancer underwent successful 6 cycles treatment with 177Lu- prostate-specific membrane antigen. On the last post therapy whole body scan a new lesion in the skull was noted, suspected for disease progression. One week later, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirayesh, Elahe, Tavakoli, Mehrdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950676/
https://www.ncbi.nlm.nih.gov/pubmed/36819190
http://dx.doi.org/10.4274/mirt.galenos.2021.55376
_version_ 1784893220939890688
author Pirayesh, Elahe
Tavakoli, Mehrdad
author_facet Pirayesh, Elahe
Tavakoli, Mehrdad
author_sort Pirayesh, Elahe
collection PubMed
description A 66-year old man known case of metastatic castration resistant prostate cancer underwent successful 6 cycles treatment with 177Lu- prostate-specific membrane antigen. On the last post therapy whole body scan a new lesion in the skull was noted, suspected for disease progression. One week later, the patient complained from weakness of left upper extremity and brain magnetic resonance imaging revealed a brain tumor, confirmed as glioblastoma pathologically.
format Online
Article
Text
id pubmed-9950676
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-99506762023-02-25 Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression Pirayesh, Elahe Tavakoli, Mehrdad Mol Imaging Radionucl Ther Interesting Image A 66-year old man known case of metastatic castration resistant prostate cancer underwent successful 6 cycles treatment with 177Lu- prostate-specific membrane antigen. On the last post therapy whole body scan a new lesion in the skull was noted, suspected for disease progression. One week later, the patient complained from weakness of left upper extremity and brain magnetic resonance imaging revealed a brain tumor, confirmed as glioblastoma pathologically. Galenos Publishing 2023-02 2023-02-23 /pmc/articles/PMC9950676/ /pubmed/36819190 http://dx.doi.org/10.4274/mirt.galenos.2021.55376 Text en ©Copyright 2023 by Turkish Society of Nuclear Medicine | Molecular Imaging and Radionuclide Therapy published by Galenos Yayınevi. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Interesting Image
Pirayesh, Elahe
Tavakoli, Mehrdad
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
title Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
title_full Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
title_fullStr Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
title_full_unstemmed Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
title_short Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
title_sort metachronous brain tumor in 177lu-psma scan in a patient with metastatic castration resistant prostate cancer mimicking disease progression
topic Interesting Image
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950676/
https://www.ncbi.nlm.nih.gov/pubmed/36819190
http://dx.doi.org/10.4274/mirt.galenos.2021.55376
work_keys_str_mv AT pirayeshelahe metachronousbraintumorin177lupsmascaninapatientwithmetastaticcastrationresistantprostatecancermimickingdiseaseprogression
AT tavakolimehrdad metachronousbraintumorin177lupsmascaninapatientwithmetastaticcastrationresistantprostatecancermimickingdiseaseprogression

Ejemplares similares